Niels Peter Louis-Hansen overdrager sin kontrollerende ejerandel til en almennyttig fond som led i et generationsskifte i milliardkoncernen Coloplast Efter 58 år i Coloplast siger Niels Peter ...
It seems Coloplast’s delay is Medtronic’s Gain. Humlebæk, Denmark-based Coloplast pushed back the estimated U.S. launch for its Intibia Tibial Nerve Stimulation device for urge urinary incontinence ...
Aug 18 (Reuters) - Medical equipment maker Coloplast (COLOb.CO), opens new tab expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments ...
Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion ...
FDA approval positions Titan Prime as Coloplast’s updated IPP option for men with severe erectile dysfunction seeking long-term prosthetic restoration of erectile function. Improved flaccid ...
Coloplast is now a clear Buy, trading nearly 60% below its all-time high and at historically low valuation multiples. CLPBF's wide economic moat, underpinned by patents and high switching costs, ...
Coloplast has named former Johnson & Johnson executive Gavin Wood as CEO, filling a vacancy that was open for 10 months. Former CEO Kristian Villumsen left the manufacturer of ostomy, continence, ...
Wie Coloplast mitteilte, war Wood zwei Jahrzehnte lang in verschiedenen Führungspositionen bei Johnson & Johnson tätig. Zuletzt leitete er Johnson & Johnson MedTech EMEA, das Geschäft des Konzerns für ...
Davis Polk is advising Coloplast A/S on its acquisition of the outstanding shares of Uromedica, Inc., which will become a wholly owned subsidiary of Coloplast. Financial terms of the transaction were ...
Com fábricas na Hungria, China e Costa Rica, a unidade de Felgueiras será a maior da multinacional dinamarquesa e um dos maiores investimentos diretos estrangeiros em Portugal dos últimos anos. A ...
Today, Coloplast is announcing changes to the company's Executive Leadership Team (ELT). The changes relate to the company's Interventional Urology business as well as the global People & Culture ...
Trotz schwieriger Börsenzeiten zeigt sich Coloplast großzügig gegenüber seinen Aktionären. Der Vorstand empfiehlt eine Jahresenddividende von 18 DKK pro Aktie, was die Gesamtdividende für das ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results